These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7381704)

  • 1. Time and temperature dependence of disintegration and correlation between dissolution and disintegration rate constants.
    Carstensen JT; Kothari R; Prasad VK; Sheridan J
    J Pharm Sci; 1980 Mar; 69(3):290-4. PubMed ID: 7381704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. USP dissolution IV: comparison of methods.
    Carstensen JT; Lai TY; Prasad VK
    J Pharm Sci; 1978 Sep; 67(9):1303-7. PubMed ID: 690839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of hardness on the disintegration time and the dissolution rate of uncoated caffeine tablets.
    Kitazawa S; Johno I; Ito Y; Teramura S; Okado J
    J Pharm Pharmacol; 1975 Oct; 27(10):765-70. PubMed ID: 241790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissolution of USP prednisone calibrator tablets: effects of stirring conditions and particle size distribution.
    Röst M; Quist PO
    J Pharm Biomed Anal; 2003 Apr; 31(6):1129-43. PubMed ID: 12667929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Automated sampling of in vitro dissolution medium: effect of sampling probes on dissolution rate of prednisone tablets.
    Savage TS; Wells CE
    J Pharm Sci; 1982 Jun; 71(6):670-3. PubMed ID: 7097531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic error associated with apparatus 2 of the USP dissolution test IV: effect of air dissolved in the dissolution medium.
    Cox DC; Furman WB; Page DP
    J Pharm Sci; 1983 Sep; 72(9):1061-4. PubMed ID: 6631694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of quinidine absorption with disintegration and dissolution rates.
    Strum JD; Ebersole JW; Jaffe JM; Colaizzi JL; Poust RI
    J Pharm Sci; 1978 Apr; 67(4):568-9. PubMed ID: 641776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of floating and sticking extended release delivery systems: an unconventional dissolution test.
    Dürig T; Fassihi R
    J Control Release; 2000 Jun; 67(1):37-44. PubMed ID: 10773327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The USP Performance Verification Test, Part I: USP Lot P Prednisone Tablets: quality attributes and experimental variables contributing to dissolution variance.
    Deng G; Ashley AJ; Brown WE; Eaton JW; Hauck WW; Kikwai LC; Liddell MR; Manning RG; Munoz JM; Nithyanandan P; Glasgow MJ; Stippler E; Wahab SZ; Williams RL
    Pharm Res; 2008 May; 25(5):1100-9. PubMed ID: 18172581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of operational characteristics of different dissolution testing systems.
    Hardwidge EA; Sarapu AC; Laughlin WC
    J Pharm Sci; 1978 Dec; 67(12):1732-5. PubMed ID: 722490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A better dissolution method for ranitidine tablets USP.
    Cappola ML
    Pharm Dev Technol; 2001; 6(1):11-7. PubMed ID: 11247270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of dissolution characteristics of polymeric and wax granulations of theophylline and their tablets.
    Uhumwangho MU; Okor RS
    Pak J Pharm Sci; 2008 Jul; 21(3):230-6. PubMed ID: 18614417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of agitation force in dissolution test and mechanical destructive force in disintegration test.
    Kamba M; Seta Y; Takeda N; Hamaura T; Kusai A; Nakane H; Nishimura K
    Int J Pharm; 2003 Jan; 250(1):99-109. PubMed ID: 12480276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of two dissolution apparatuses with correlation of in vitro-in vivo data for prednisone and prednisolone tablets.
    Milsap RL; Ayres JW; Mackichan JJ; Wagner JG
    Biopharm Drug Dispos; 1979; 1(1):3-17. PubMed ID: 552859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative studies on eight dissolution method using 21 commercial chloramphenicol tablets and a nondisintegrating benzoic acid tablet.
    Ogata H; Shibazaki T; Inoue T; Ejima A
    J Pharm Sci; 1979 Jun; 68(6):708-12. PubMed ID: 458569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generated surface area measurement of disintegrating tablets.
    Rubinstein MH; Wells JI
    J Pharm Pharmacol; 1977 Jun; 29(6):363-6. PubMed ID: 18574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on different dissolution models. IV. Erosion of tablets.
    De Haan P; Lerk CF
    Pharm Weekbl Sci; 1982 Dec; 4(6):191-6. PubMed ID: 7155788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collaborative study of the USP dissolution test for prednisone tablets with Apparatus 2.
    Cox DC; Furman WB
    J Pharm Sci; 1984 May; 73(5):670-6. PubMed ID: 6737242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of in vitro test conditions on release of aspirin from commercial tablets.
    Nikolić L; Djurić Z; Jovanović M
    J Pharm Sci; 1992 Apr; 81(4):386-91. PubMed ID: 1501078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic error associated with apparatus 2 of the USP dissolution test III: limitations of calibrators and the USP suitability test.
    Cox DC; Furman WB; Thornton LK; Moore TW; Jefferson EH
    J Pharm Sci; 1983 Aug; 72(8):910-3. PubMed ID: 6620145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.